Adaptive Biotechnologies Corp 10-Q filing
Filed 2025-08-05 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-103120
- Form type
- 10-Q
- CIK
- 0001478320
- Primary document
- https://www.sec.gov/Archives/edgar/data/1478320/000095017025103120/adpt-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Adaptive Biotechnologies Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $111.3M | - | - |
| Cost Of Revenue | $35.0M | - | - |
| Operating Income | $-54.6M | - | - |
| Net Income | $-55.5M | - | - |
| Eps Basic | -0.37 | - | - |
| Eps Diluted | -0.37 | - | - |
| Cash And Equivalents | $43.2M | - | - |
| Total Assets | $496.6M | - | - |
| Total Liabilities | $317.1M | - | - |
| Shareholders Equity | $179.7M | - | - |
| Operating Cash Flow | $-40.9M | - | - |
| Capital Expenditures | $1.9M | - | - |